NCT06053645Recruiting
The Weight of Cardiovascular Disease
Mayo Clinic
Start Date
4/22/2024
Completion Date
7/1/2026
Summary
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* BMI ≥30 kg/m2
* At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
* Patients evaluated in the Cardiometabolic clinic
* Willingness to complete questionnaires/surveys
* Ability to complete monthly self-assessments at home
Exclusion Criteria:
* BMI \<30 kg/m2
* Pregnancy or lactating women
* Hemodynamically unstable CVD
* Active malignancy
* Autoimmune or systemic inflammatory diseases
* Severe renal or hepatic failure
* Being considered unsafe to participate as determined by the study physician
* Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
* Patients with active psychosis, mania, or substance use disorders
Conditions
Cardiovascular DiseasesObesity
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States